Blood Pressure Must be Controlled
The same thing was expressed by the Head of Hypertension Working Group PERKI, dr. Badai Bhatara Tiksnadi, Sp.JP(K), FIHA, MM. He pointed out how a person’s blood pressure must be controlled according to existing comorbidities. “Hypertensive patients should continue to take hypertension drugs recommended by doctors to keep their blood pressure from rising. They have to be sure that the diagnosis of hypertension is carried out with measurement techniques correctly and accurately. In addition to drugs, blood pressure control can be done by non-pharmacological methods, such as using a digital blood pressure monitor, limiting salt intake, regular moderate-intensity physical exercise, and achieving an ideal body weight. Regular blood pressure monitoring at home is an effective way to detect and manage hypertension to prevent various kinds of dangerous health complications, such as heart disease, stroke, and even death.”
Meanwhile, Tomoaki Watanabe, Director of Omron Healthcare Indonesia, stated that his organization will continue their support towards commemoration of WHD 2022, and they are committed to increase public awareness of the benefits of regular BP monitoring at home. “We also want to state that blood pressure monitoring must be accompanied by lifestyle changes and treatment measures to ensure the ideal management of hypertension. This is in line with our vision towards creating a world free of cardiovascular disease events (Going for Zero-through preventive care) via propagating the habit of regular blood pressure monitoring, controlling hypertension actively and taking steps towards behavioral changes, to overcome habits that can increase the risk of heart attacks,” he said.
Going For Zero Vision in the cardiovascular business domain covers: contributing to hypertension control by designing innovative devices; evolution of the treatment of chronic diseases via acceleration of Remote Patient Monitoring (RPM) services, and developing artificial intelligence (AI) based technologies to analyze vital body data at home to support the diagnosis and treatment of hypertensive patients. “We are committed to contribute towards lowering the number of episodes (events) which are sometimes mortal and may lead patients to a bed-ridden status to zero. We are challenging ourselves to develop devices and services to enable people detect hypertension and arrhythmia – the risk factors at an early stage – and prevent the onsets of events, thus supporting people in the effort to improve their lifestyle habits and add value to their home health management via monitoring, to contribute to healthier and more fulfilling lives,” he concluded. (est)